Menchu Lavid
About Menchu Lavid
Menchu Lavid is the Corporate Affairs Director for Spain & Portugal at Bristol Myers Squibb, with extensive experience in the pharmaceutical sector and a background in medicine and microbiology.
Corporate Affairs Director at Bristol Myers Squibb
Menchu Lavid currently holds the position of Corporate Affairs Director for Spain & Portugal at Bristol Myers Squibb. In this role, she oversees corporate communications, government affairs, market access, and strategic planning for the company's operations in these regions. Her responsibilities include managing relationships with key stakeholders and aligning corporate strategies with local market dynamics.
Previous Roles at Hospira and ESIC Business & Marketing School
Before joining Bristol Myers Squibb, Menchu Lavid served as Head of Market Access, Government Affairs & Communication at Hospira from 2014 to 2016 in Madrid, Spain. In this capacity, she was responsible for navigating market access strategies and coordinating governmental relationships. She was also a Visiting Professor at ESIC Business & Marketing School from 2013 to 2014, where she imparted knowledge and practical insights to students in the Madrid Area.
Long Tenure at Merck Sharp & Dohme
Menchu Lavid's career includes a significant 14-year tenure at Merck Sharp & Dohme (MSD), where she held the role of Policy and Communication Director from 1999 to 2013. Prior to this, she led the Antiinfectives Disease Unit from 1994 to 1999. Her responsibilities at MSD included managing policy communications and directing strategic initiatives focused on anti-infective diseases.
Early Career at GlaxoSmithKline
Menchu Lavid began her career at GlaxoSmithKline, working as the Antiinfectives Diseases Unit Manager from 1992 to 1994. During this time, she managed projects related to anti-infective diseases, contributing to the development and implementation of strategic health initiatives.
Educational Background: Universidad Autónoma de Madrid
Menchu Lavid earned her medical degree in Medicine and Surgery from the Universidad Autónoma de Madrid, where she studied from 1979 to 1985. She further specialized in Microbiology and Parasitology from 1985 to 1990 at the same institution. Her educational background has provided her with a solid foundation in medical sciences, which she has applied throughout her career in the pharmaceutical sector.